Legal Opinion
Senju Pharmaceutical Co. v. Metrics, Inc.
District Court, D. New Jersey
Decided March 31, 2015No. Civil Action No. 14-3962 (JBS/KMW)PublishedCited by 33 opinions
1Opinion of the Court
OPINION
SIMANDLE, Chief Judge:
I. INTRODUCTION
This is a patent infringement action brought by Plaintiffs Senju Pharmaceutical Company, Bausch & Lomb, Inc., and its subsidiary, Bauch & Lomb Pharma Holdings Corp. Plaintiffs hold the rights to three patents for novel formulations of bromfenac, an active ingredient in Prolen-sa®, a drug that is used to treat patients who have undergone cataract surgery. Plaintiffs filed this cáse on June 20, 2014, alleging that Defendants infringed upon their patents by submitting Abbreviated New Drug Applications (“ANDAs”) seeking FDA approval for the manufacture…
2Cases cited55 opinions
- International Shoe Co. v. WashingtonSupreme Court of the United States · 1945
- Burger King Corp. v. RudzewiczSupreme Court of the United States · 1985
- World-Wide Volkswagen Corp. v. WoodsonSupreme Court of the United States · 1980
- Hanson v. DencklaSupreme Court of the United States · 1958
- Helicopteros Nacionales De Colombia, S. A. v. HallSupreme Court of the United States · 1984
50 more not listed; retrieve them via the Exa API.
3Cited by33 opinions
- Display Works, LLC v. BartleyDistrict Court, D. New Jersey · 2016
- Genuine Parts Co. v. CepecSupreme Court of Delaware · 2016
- Dutch Run-Mays Draft, LLC v. Wolf Block, LLPNew Jersey Superior Court Appellate Division · 2017
- Magna Powertrain De Mexico S.A. De C.V. v. Momentive Performance Materials USA LLCDistrict Court, E.D. Michigan · 2016
- Public Impact, LLC v. Boston Consulting Group, Inc.District Court, M.D. North Carolina · 2015
28 more not listed; retrieve them via the Exa API.